Tengjun Biotechnology Corp.: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $150.1M
- Net Income/Loss (FY2022)
- $12.0M
- Total Assets (FY2022)
- $58.6M
- Total Equity (FY2022)
- $15.0M
- Cash Flows from Operating Activities (FY2022)
- $1.3M
Source: Tengjun Biotechnology Corp. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
